SEATTLE, Feb. 20, 2019 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) CTIC today announced that management will provide a corporate overview at the 8th Annual SVB Leerink Global Healthcare Conference at 11:30 a.m. EST at the Lotte New York Palace Hotel.
Presentation details: | |
Event: | 8th Annual SVB Leerink Global Healthcare Conference |
Date: | Wednesday, Feb. 27 |
Time: | 11:30 a.m. EST |
The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma's website at www.ctibiopharma.com.
About CTI BioPharma Corp.
CTI BioPharma Corp. is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer a unique benefit to patients and healthcare providers. The CTI BioPharma lead product candidate, pacritinib, is being developed for the treatment of patients with myelofibrosis. CTI BioPharma is headquartered in Seattle, Washington. For additional information and to sign up for email alerts and get RSS feeds, please visit www.ctibiopharma.com.
CTI BioPharma Investor Contacts:
Argot Partners
Maeve Conneighton
+1-212-600-1902
CTI@argotpartners.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/cti-biopharma-to-present-at-the-8th-annual-svb-leerink-global-healthcare-conference-wednesday-feb-27-300798518.html
SOURCE CTI BioPharma Corp.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.